COVID-19 and the liver-related deaths to come

Nature Reviews Gastroenterology & Hepatology, Published online: 11 June 2020; doi:10.1038/s41575-020-0328-2Coronavirus disease 2019 (COVID-19) itself and/or the use of hepatotoxic drugs might negatively affect the course and management of patients with pre-existing chronic liver diseases. However, the greatest effect of COVID-19 on liver diseases will be indirect and delayed, resulting from the impending global economic crisis.

http://feeds.nature.com/~r/nrgastro/rss/current/~3/Xok2XQlODJQ/s41575-020-0328-2

Source: Nature Reviews Gastroenterology and Hepatology - June 10, 2020 Category: Gastroenterology Authors: Jean-Michel Pawlotsky Source Type: research

More News: COVID-19 | Gastroenterology | Liver | Liver Disease | Urology & Nephrology